Home >  Neurology and Neurosurgery MDTV >  Neurology & Neurosurgery Shorts >  New Study Explains How...

New Study Explains How Inflammation Weakens Muscles During Illness

By - Anshika Mishra
Published On 2024-07-16 03:00 GMT   |   Update On 2024-07-16 03:00 GMT
Advertisement
Infections and neurodegenerative diseases cause inflammation in the brain. However, for unknown reasons, patients with brain inflammation often develop muscle problems that seem to be independent of the central nervous system.
Now, researchers at Washington University School of Medicine in St. Louis have revealed how brain inflammation releases a specific protein that travels from the brain to the muscles and causes a loss of muscle function.
The study, published in the journal Science Immunology, and conducted in fruit flies and mice, also identified ways to block this process, which could have implications for treating or preventing the muscle wasting sometimes associated with inflammatory diseases, including bacterial infections, Alzheimer's disease and long COVID.
In the study, researchers investigated the effects of brain inflammation on muscle function by modeling three diseases: an E. coli bacterial infection, a SARS-CoV-2 viral infection, and Alzheimer's disease.
Advertisement
They found that brain inflammation caused by these diseases leads to the buildup of reactive oxygen species, which in turn triggers the production of interleukin-6 (IL-6). IL-6 then travels through the bloodstream and reduces energy production in muscle mitochondria. This was observed in both mice and fruit flies.
The study suggested that IL-6 activates the JAK-STAT pathway in muscles, causing decreased mitochondrial function. This pathway can be blocked by existing FDA-approved JAK inhibitors and monoclonal antibodies against IL-6, offering potential treatments for muscle weakness related to brain inflammation.
"We are interested in understanding the very deep muscle fatigue that is associated with some common illnesses. Our study suggests that when we get sick, messenger proteins from the brain travel through the bloodstream and reduce energy levels in skeletal muscle. This is more than a lack of motivation to move because we don't feel well. These processes reduce energy levels in skeletal muscle, decreasing the capacity to move and function normally,” said senior author Aaron Johnson, PhD, an associate professor of developmental biology.
“In the study, flies and mice with COVID-associated proteins in their brains exhibited reduced motor function. Flies had difficulty climbing, while mice ran less and with less efficiency compared to controls. Similar muscle function impairments were observed when the brain was exposed to bacterial-associated proteins and the Alzheimer's protein amyloid beta. The researchers noted that these effects could become chronic, with reduced muscle performance persisting long after the initial infection was cleared..”
Reference: Yang, S., et al. (2024) Infection and chronic disease activate a systemic brain-muscle signaling axis; Washington University School of Medicine; Science Immunology. doi.org/10.1126/sciimmunol.adm7908.
Full View
Tags:    
Article Source : Science Immunology

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Anshika Mishra

Anshika Mishra is a dedicated scholar pursuing a Masters in Biotechnology, driven by a profound passion for exploring the intersection of science and healthcare. Having embarked on this academic journey with a passion to make meaningful contributions to the medical field, Anshika joined Medical Dialogues in 2023 to further delve into the realms of healthcare journalism.

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Study Reveals How Green Spaces May Protect Children Against ADHD and Autism

Is Air Pollution Quietly Increasing Brain Tumour Risk? Study Sheds Light

Even Low Lead Exposure May Accelerate Memory Loss in Children: Study Finds

Improved Survival Rates for People with Dementia: Global Study Finds

Is Your Brain Aging Too Fast? New Study Can Tell from One Brain Scan

Even in Your 70s, Your Brain May Be Making New Memory Cells: Study Suggests

New AI Tool Accurately Detects Nine Types of Dementia Using Single Brain Scan: Study Shows

Can Electric Fields Help Heal Spinal Cord Injuries? Study Provides Insights